Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen T Abedon

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Pharmaceuticals (Basel, Switzerland)|September 16, 2015
Ecology of Anti-Biofilm Agents I: Antibiotics versus BacteriophagesStephen T Abedon
Frontiers in Microbiology|August 26, 2016
Commentary: Phage Therapy of Staphylococcal Chronic Osteomyelitis in Experimental Animal ModelStephen T Abedon
Pharmaceuticals (Basel, Switzerland)|May 5, 2017
Information Phage Therapy Research Should ReportStephen T Abedon
Bacteriophage|April 26, 2013
Envisaging bacteria as phage targetsStephen T Abedon
Bacteriophage|January 1, 2013
Thinking about microcolonies as phage targetsStephen T Abedon
Microbiology Spectrum|August 26, 2017
Bacteriophage Clinical Use as Antibacterial "Drugs": Utility and PrecedentStephen T Abedon
Viruses|July 4, 2012
Spatial vulnerability: bacterial arrangements, microcolonies, and biofilms as responses to low rather than high phage densitiesStephen T Abedon
Drugs and Drug Candidates|May 21, 2024
Schlesinger Nailed It! Assessing a Key Primary Pharmacodynamic Property of Phages for Phage Therapy: Virion Encounter Rates with Motionless Bacterial TargetsStephen T Abedon
Antibiotics (Basel, Switzerland)|September 28, 2023
Automating Predictive Phage Therapy PharmacologyStephen T Abedon
Frontiers in Microbiology|June 17, 2017
Commentary: Communication between Viruses Guides Lysis-Lysogeny DecisionsStephen T Abedon
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Pharmaceuticals (Basel, Switzerland)|September 16, 2015
Ecology of Anti-Biofilm Agents I: Antibiotics versus BacteriophagesStephen T Abedon
Frontiers in Microbiology|August 26, 2016
Commentary: Phage Therapy of Staphylococcal Chronic Osteomyelitis in Experimental Animal ModelStephen T Abedon
Pharmaceuticals (Basel, Switzerland)|May 5, 2017
Information Phage Therapy Research Should ReportStephen T Abedon
Bacteriophage|April 26, 2013
Envisaging bacteria as phage targetsStephen T Abedon
Bacteriophage|January 1, 2013
Thinking about microcolonies as phage targetsStephen T Abedon
Microbiology Spectrum|August 26, 2017
Bacteriophage Clinical Use as Antibacterial "Drugs": Utility and PrecedentStephen T Abedon
Viruses|July 4, 2012
Spatial vulnerability: bacterial arrangements, microcolonies, and biofilms as responses to low rather than high phage densitiesStephen T Abedon
Drugs and Drug Candidates|May 21, 2024
Schlesinger Nailed It! Assessing a Key Primary Pharmacodynamic Property of Phages for Phage Therapy: Virion Encounter Rates with Motionless Bacterial TargetsStephen T Abedon
Antibiotics (Basel, Switzerland)|September 28, 2023
Automating Predictive Phage Therapy PharmacologyStephen T Abedon
Frontiers in Microbiology|June 17, 2017
Commentary: Communication between Viruses Guides Lysis-Lysogeny DecisionsStephen T Abedon
Pageof 8